IBDEI10E ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16414,0)
 ;;=R39.192^^61^772^73
 ;;^UTILITY(U,$J,358.3,16414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16414,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,16414,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,16414,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,16415,0)
 ;;=R97.21^^61^772^103
 ;;^UTILITY(U,$J,358.3,16415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16415,1,3,0)
 ;;=3^Rising PSA After Tx for Prostate CA
 ;;^UTILITY(U,$J,358.3,16415,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,16415,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,16416,0)
 ;;=N50.82^^61^772^104
 ;;^UTILITY(U,$J,358.3,16416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16416,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,16416,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,16416,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,16417,0)
 ;;=N50.812^^61^772^108
 ;;^UTILITY(U,$J,358.3,16417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16417,1,3,0)
 ;;=3^Testicular Pain,Left Side
 ;;^UTILITY(U,$J,358.3,16417,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,16417,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,16418,0)
 ;;=N50.811^^61^772^109
 ;;^UTILITY(U,$J,358.3,16418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16418,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,16418,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,16418,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,16419,0)
 ;;=N35.919^^61^772^114
 ;;^UTILITY(U,$J,358.3,16419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16419,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,16419,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,16419,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,16420,0)
 ;;=N35.92^^61^772^113
 ;;^UTILITY(U,$J,358.3,16420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16420,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,16420,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,16420,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,16421,0)
 ;;=R82.81^^61^772^101
 ;;^UTILITY(U,$J,358.3,16421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16421,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,16421,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,16421,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,16422,0)
 ;;=N18.30^^61^772^17
 ;;^UTILITY(U,$J,358.3,16422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16422,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3 Unspec
 ;;^UTILITY(U,$J,358.3,16422,1,4,0)
 ;;=4^N18.30
 ;;^UTILITY(U,$J,358.3,16422,2)
 ;;=^5159286
 ;;^UTILITY(U,$J,358.3,16423,0)
 ;;=N18.31^^61^772^18
 ;;^UTILITY(U,$J,358.3,16423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16423,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3a
 ;;^UTILITY(U,$J,358.3,16423,1,4,0)
 ;;=4^N18.31
 ;;^UTILITY(U,$J,358.3,16423,2)
 ;;=^5159287
 ;;^UTILITY(U,$J,358.3,16424,0)
 ;;=N18.32^^61^772^19
 ;;^UTILITY(U,$J,358.3,16424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16424,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3b
 ;;^UTILITY(U,$J,358.3,16424,1,4,0)
 ;;=4^N18.32
 ;;^UTILITY(U,$J,358.3,16424,2)
 ;;=^5159288
 ;;^UTILITY(U,$J,358.3,16425,0)
 ;;=G44.1^^61^773^10
 ;;^UTILITY(U,$J,358.3,16425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16425,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,16425,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,16425,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,16426,0)
 ;;=G43.909^^61^773^6
 ;;^UTILITY(U,$J,358.3,16426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16426,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
